Overcoming Challenges Facing Advanced Therapies in the EU Market.

Abstract

While advanced therapy medicinal products offer great clinical promise, most EU-approved products have not achieved satisfactory commercial performance. Here we highlight a number of issues that prevent current products from obtaining commercial success and pitfalls that developers must overcome in future product development. 
DOI: 10.1016/j.stem.2016.08.012

Topics

2 Figures and Tables

Cite this paper

@article{AbouElEnein2016OvercomingCF, title={Overcoming Challenges Facing Advanced Therapies in the EU Market.}, author={Mohamed Abou-El-Enein and Ahmed Elsanhoury and Petra Reinke}, journal={Cell stem cell}, year={2016}, volume={19 3}, pages={293-7} }